Health :: Drugs & Medications

How a Carmel medical clinic treats those in need

indystar.com

How a Carmel medical clinic treats those in need


Read More ...

State reverses restrictive policy on hepatitis C drugs

stltoday.com

State reverses restrictive policy on hepatitis C drugs


Read More ...

Drugs infiltrating Plymouth treatment center: 5 Investigates

wcvb.com

Drugs infiltrating Plymouth treatment center: 5 Investigates


Read More ...

Health nominee reaped big earnings from drug industry tenure

ktvn.com

Health nominee reaped big earnings from drug industry tenure


Read More ...

Health Matters: When to take blood-thinning medication and aspirin

inforum.com

Health Matters: When to take blood-thinning medication and aspirin


Read More ...

FDA to crack down on risky stem cell offerings

bostonglobe.com

FDA to crack down on risky stem cell offerings


Read More ...

Popular Stories

Home / United States / Health / Drugs & Medications
Walgreens installs time-delayed safes in its pharmacies - Dauer: 15 Sekunden
Walgreens is taking measures to reduce drug robberies.   Read More ...
Categories: Health | 
Tags: Pharmacies/Chemists | 
Places: Americas |  North America |  United States |  Northeast |  New England |  Connecticut | 
Walgreens taking measures to reduce pharmacy robberies
Related Coverage (WTNH)–Walgreens is taking measures to reduce pharmacy robberies. The company has installed time-delayed safes in its pharmacies across several states. These safes are not used to store money, but protect the drugs that thieves often target from pharmacies. Walgreens says criminals are less likely to rob a pharmacy when they know they will have to wait for a safe to open   Read More ...
Categories: Health |  Law & Crime | 
Places: Americas |  North America |  United States |  Northeast |  New England |  Connecticut | 
German therapist convicted of botched psychedelic experiment
BERLIN (AP) - A German psychotherapist has been sentenced to probation after confessing to providing a group of alternative practitioners with psychedelic drugs as part of a seminar on expanding consciousness. The 2015 seminar resulted in the hospitalization of the 27 participants with cramps, delirium and other complications from ingesting the psychedelic drug 2C-E and also an extremely potent hallucinogen known as DragonFLY   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: United States |  Germany |  Berlin-Brandenburg | 
Scientists explore drug's value in treating both alcoholism and PTSD
The link between addiction and mental health disorders may be firmly established in scientific circles, but treatments designed to address them together are uncommon. Some University of Maryland researchers may be taking a promising step to tackle two such intractable, but often related conditions: alcoholism and post-traumatic stress disorder. Dr. Bankole Johnson, an addiction and brain science expert and professor of psychiatry in the University of Maryland School of Medicine, is leading a team launching a five-year study of the effectiveness of a drug called pregablin for treating alcoholism and PTSD together   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States |  American South |  Atlantic |  Maryland | 
SCI Camp Hill inmate got over-the-counter drugs before cancer death
MONTPELIER, Vt. — A Vermont inmate who died of cancer at a Pennsylvania prison wrote in a diary that he repeatedly asked for medical care but was denied and given ibuprofen and Tylenol for his pain. Roger Brown didn't know he had lung cancer, a lawyer for his widow said. The 68-year-old died Oct. 15 at the state prison in Camp Hill, Pennsylvania   Read More ...
Categories: Health |  Law & Crime | 
Places: Americas |  North America |  United States |  Northeast |  Vermont |  Atlantic |  Pennsylvania |  Montpelier | 
How a Carmel medical clinic treats those in need
CARMEL, Ind. — Carlos Fernandez was in a tough spot when the company he worked for changed hands and he lost his job of 25 years, along with his health insurance. Fernandez, 48, Carmel, has Type 2 diabetes, and he said his medication costs $900 per month. Unable to afford the life-saving drug, he turned to the Trinity Free Clinic. , a faith-based nonprofit medical facility that operates from a building on the campus of Our Lady of Mount Carmel Catholic Church   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States |  Midwest |  East |  Indiana | 
U.S. FDA approves first two-drug HIV regimen in win for GSK
(Reuters) - The U.S. Food and Drug Administration has approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at lessening the side effect burden of current treatments that combine three or four medicines. The green light is a boost for GlaxoSmithKline , whose Chief Executive Emma Walmsley counts the medicine among three products that are “critical” to help fill a revenue gap left by falling sales of the ageing lung drug Advair   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
State reverses restrictive policy on hepatitis C drugs
The state of Missouri is reversing course and will allow anyone on Medicaid with hepatitis C to receive the medication that cures the disease. The change in policy comes after a lawsuit was filed against the department that oversees the state's Medicaid program, arguing that some Medicaid patients were denied medically necessary treatment. The case, filed in federal court in Missouri's western district last year, was dismissed Monday following the state's decision to change its policy, effective Nov   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States |  Midwest |  West |  Missouri | 
U.S. FDA approves first two-drug HIV regimen from GSK
NEW YORK (Reuters) - The U.S. Food and Drug Administration on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at lessening the side effect burden of current treatments that combine three or four medicines. The treatment, called Juluca, is a fixed-dose tablet that combines two previously approved drugs, dolutegravir and rilpivirine, and is available to patients who have been on a stable regimen for at least six months   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Millions face pain, withdrawal as opioid prescriptions plummet
Six months after surgery to repair a damaged urinary tract in 1998, computer technician Doug Hale woke one morning with excruciating, burning pain. Hale's suffering persisted for years, despite all sorts of treatments. Finally, in 2006, he was prescribed strong doses of opioids. Fast-forward 10 years. Still on his pain killers, Hale was popping so many of the highly addictive pills that he regularly ran out of his prescription early   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States |  West |  Mountain |  Utah | 
Families in limbo after FDA rejection of new drug for muscular dystrophy
  Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States | 
Families in limbo after FDA rejection of new drug for muscular dystrophy
  Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States |  Midwest |  West |  North Dakota | 
Three things Trump can do to bring drug prices ‘way down’
Amy Kapczynski is a professor of law at Yale Law School. Aaron S. Kesselheim is an associate professor of medicine at Harvard Medical School and a faculty member at Brigham and Women’s Hospital. President Trump nominated Alex Azar to serve the next secretary of health and human services last week, that he would be “a star for better healthcare and lower drug prices!” In fact, Trump has made many grand claims that he will bring drug prices “way down   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States | 
Keep the Pentagon out of drug approvals
Motivated by concern for the health of American troops, members of Congress have proposed solving a hypothetical military problem with a real medical mistake. Their provision to allow the military to approve use of drugs and devices, bypassing the pros at the Food and Drug Administration, would open a loophole in federal drug-approval laws that practically invites unintended consequences. It could even backfire, by turning the service members it’s meant to protect into unwilling test subjects for unapproved products   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Cytokinetics sinks on abandoning ALS drug after failed trial
(Reuters) - Cytokinetics Inc shares plummeted nearly 28 percent on Tuesday after the drugmaker said it would stop developing one of its treatments for ALS, a fatal neuro-degenerative disorder, after the drug failed to improve lung function in a key trial. Amyotrophic lateral sclerosis, also called Lou Gehrig’s disease, is a condition that affects nerve cells in the brain and the spinal cord, with deaths and disability in patients mainly caused by respiratory failure   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
U.S. FDA approves first two-drug HIV regimen
NEW YORK (Reuters) - The U.S. Food and Drug Administration on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at easing the side effects for long-term patients who are on the standard treatment involving three or more drugs. The treatment, called Juluca, is a fixed-dose tablet that combines two previously approved drugs, dolutegravir and rilpivirine, and is available to patients who have been on a stable regimen for at least six months   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Startup wants to bring back Vioxx for hemophilia joint pain
TRENTON, N.J. (AP) - Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so. Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke. Now tiny Tremeau Pharmaceuticals is working to bring it back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
The Latest: Startup could bring back Vioxx for hemophilia
TRENTON, N.J. (AP) - The Latest on the possible return of Vioxx (all times local): Could the once-popular arthritis pill Vioxx (VEYE-ochs) get a second life? A startup pharmaceutical company hopes so. In 2004, Merck & Co. voluntarily pulled the blockbuster drug amid evidence it doubled the chances of having a heart attack or stroke. Now tiny Tremeau (treh-MOH') Pharmaceuticals is working to Vioxx back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Ohio billboard campaign to tackle drug abuse problem
COLUMBUS, Ohio (AP) — State officials say a new billboard campaign will be used to raise public awareness about drug abuse and the need for public participation in tackling the problem throughout Ohio. The Ohio Outdoor Advertising Association of Ohio and Ohio's Department of Public Safety and Department of Mental Health and Addiction Services launched the campaign Tuesday. Officials say association members are donating about 200 digital, poster, and bulletin billboards with the messages: "Start Talking!" and "#677 for Impaired Drivers   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States |  Ohio |  Columbus | 
Inmate got over-the-counter drugs before cancer death
MONTPELIER, Vt. (AP) — A Vermont inmate who died of cancer at a Pennsylvania prison wrote in a diary that he repeatedly asked for medical care but was denied and given ibuprofen and Tylenol for his pain. Sixty-eight-year-old Roger Brown died Oct. 15 at the state prison in Camp Hill, Pennsylvania. The Pennsylvania Department of Corrections is reviewing the death. The Vermont Department of Corrections will do the same   Read More ...
Categories: Health | 
Tags: Drugs & Medications |  Cancer | 
Places: Americas |  North America |  United States |  Vermont |  Montpelier | 
Cancer drugs could control high blood pressure 
Drugs that fight cancer may also be used to control high blood pressure, according to a new Georgetown University study. Researchers have called the finding a real advance in the treatment of high blood pressure. While there are numerous hypertension drugs, not every therapy works for every patient. The study, published in the journal Hypertension, revealed that fibroblast growth factors, or FGF’s, which drive blood vessel growth so that cancer can grow, also have a systemic effect on blood pressure   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
The new oxy? There's another popular prescription drug to watch - | WBTV Charlotte
(WWBT) - In the midst of a nationwide opioid addiction crisis, a different type of drug may be slipping in under the radar. Instead of prescribing opioids, this drug was thought to be just what the doctor ordered for some patients. But there's a growing body of research uncovering the misuse of it. And now there's even a black market for this popular prescription - gabapentin - being sold cheaply on the streets, with the slang name “johnnys   Read More ...
Categories: Health | 
Johnson & Johnson drug succeeds in newly diagnosed multiple myeloma patients: study
(Reuters) - Johnson & Johnson’s blockbuster multiple myeloma drug Darzalex when added to a standard therapy regimen reduced the risk of disease progression or death by 50 percent compared with standard therapy alone in patients not previously treated for the blood cancer, according to data released on Tuesday. The data could lead to expanded approvals of the Darzalex combination as an initial, or first-line, therapy for multiple myeloma, providing a larger sales opportunity for the medicine, one of J&J’s most important growth drivers   Read More ...
Categories: Health | 
Tags: Drugs & Medications |  Patients |  Diagnosis | 
Places: United States | 
Startup could bring back Vioxx for hemophilia
TRENTON, N.J. | Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so. Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke. Now tiny Tremeau Pharmaceuticals is working to bring it back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
The new oxy? There's another popular prescription drug to watch
(WWBT) - In the midst of a nationwide opioid addiction crisis, a different type of drug may be slipping in under the radar. Instead of prescribing opioids, this drug was thought to be just what the doctor ordered for some patients. But there's a growing body of research uncovering the misuse of it. And now there's even a black market for this popular prescription - gabapentin - being sold cheaply on the streets, with the slang name “johnnys   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
The Latest: Startup could bring back Vioxx for hemophilia
TRENTON, N.J. (AP) — The Latest on the possible return of Vioxx (all times local): Could the once-popular arthritis pill Vioxx (VEYE-ochs) get a second life? A startup pharmaceutical company hopes so. In 2004, Merck & Co. voluntarily pulled the blockbuster drug amid evidence it doubled the chances of having a heart attack or stroke. Now tiny Tremeau (treh-MOH') Pharmaceuticals is working to Vioxx back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Startup wants to bring back Vioxx for hemophilia joint pain
TRENTON, N.J. (AP) - Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so. Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke. Now tiny Tremeau Pharmaceuticals is working to bring it back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
The Latest: Startup could bring back Vioxx for hemophilia
TRENTON, N.J. (AP) — The Latest on the possible return of Vioxx (all times local): Could the once-popular arthritis pill Vioxx (VEYE-ochs) get a second life? A startup pharmaceutical company hopes so. In 2004, Merck & Co. voluntarily pulled the blockbuster drug amid evidence it doubled the chances of having a heart attack or stroke. Now tiny Tremeau (treh-MOH') Pharmaceuticals is working to Vioxx back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Startup could bring back Vioxx for hemophilia
TRENTON, N.J. (AP) - Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so. Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke. Now tiny Tremeau Pharmaceuticals is working to bring it back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Roche, AbbVie leukemia drug superior to older medicine in study
(Reuters) - Patients with a type of leukemia that had relapsed who received the new drug Venclexta in combination with Rituxan went significantly longer without the disease worsening than those treated with Rituxan and Treanda, according to interim results from a pivotal late stage study released on Tuesday. Venclexta, sold by Roche and AbbVie, received an accelerated approval to treat chronic lymphocytic leukemia (CLL) patients with a specific genetic mutation who received at least one prior therapy   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Startup could bring back Vioxx for hemophilia
TRENTON, N.J. (AP) - Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so. Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke. Now tiny Tremeau Pharmaceuticals is working to bring back it back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Local group pushes for safe place where addicts can use drugs, access treatment
PORTLAND, Ore. — A relatively new organization hopes to build Oregon’s first safe-consumption site in the Rose City, where addicts can get clean supplies and use drugs while being supervised by medical professionals. It's an alternative way to fight the opioid crisis and reduce overdose deaths. Sam Chapman founded Safer Spaces Portland just a few months ago, but says he’s already begun talking with city and county officials about a safe-consumption site   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States |  Portland | 
Startup could bring back Vioxx for hemophilia
TRENTON, N.J. (AP) - Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so. Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke. Now tiny Tremeau Pharmaceuticals is working to bring back it back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Startup could bring back Vioxx for hemophilia
TRENTON, N.J. (AP) — Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so. Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke. Now tiny Tremeau Pharmaceuticals is working to bring back it back, to treat severe joint pain caused by the bleeding disorder hemophilia   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Drug firm Concordia overcharged Britain's health service with 6,000 percent price rise
LONDON (Reuters) - Drug company Concordia overcharged Britain’s health service millions of pounds for an essential thyroid drug by abusing its position as the only supplier, the country’s Competition and Markets Authority said on Tuesday. The National Health Service spent 34 million pounds ($45 million) on liothyronine tablets last year, up from 600,000 pounds a decade ago, after Concordia increased the price per pack by almost 6,000 percent from 4   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States |  United Kingdom | 
Britain says Canada's Concordia overcharging health service for thyroid drug
LONDON (Reuters) - Drug company Concordia overcharged Britain’s health service millions of pounds for an essential thyroid drug by abusing its position as the only supplier, the country’s Competition and Markets Authority said on Tuesday. The National Health Service spent 34 million pounds ($45 million) on liothyronine tablets last year, up from 600,000 pounds a decade ago, after Concordia increased the price per pack by almost 6,000 percent from 4   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States |  Canada |  United Kingdom | 
Drugs for pain and depression added up to a dangerous cocktail
I have been taking tramadol, amitriptyline and sertraline for more than three years. I was having a hard time with my depression and told my doctor it was getting worse. She increased the dose of sertraline from 100 mg to 150 mg. Five days later, I had a seizure. Nobody could understand why. My electrolytes were abnormal, so I went back to see the doctor a few weeks later and asked if the increased dosage could have been the cause   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States |  American South |  Atlantic |  Georgia | 
Drugs infiltrating Plymouth treatment center: 5 Investigates
WEBVTT FORECAST, AS WELL AS TRAFFIC ANDTRAVEL UPDATES ALL EVENING LONG.NOW TO THIS -- 5 INVESTIGATESTONIGHT DRUGS, OVERDOSES ANDDEATH IN DETOX.THIS AS SO MANY CONTINUE TOSTRUGGLE WITH SUBSTANCE ABUSE INTHE GRIP OF A DEADLY EPIDEMIC.ED: KATHY CURRAN HAS BEENDIGGING INTO THE ISSUE OF DRUGSSOME OF THE MOST DIFFICULTADDICTION CASES IN THE STATE.[SIREN]>> THE NURSE IS ATTEMPTING TONARC CAN THE PATIENT.KATHY: IN DETOX, ON THE FLOOR,UNRESPONSIVE, NOT BREATHING   Read More ...
Categories: Health | 
Tags: Drugs & Medications |  Patients |  Treatment | 
Places: Americas |  North America |  United States | 
Magnetic Field Controls Drug Delivery
Researchers have developed a new way to control the delivery of drugs to the body using nanoparticles and a weak magnetic field. The inventors, at the University of Georgia in Athens, GA tested their system with a chemotherapy drug, and published the results today in the journal Nature Catalysis. Patients undergoing treatments for cancer and other diseases often must take drugs that affect the whole body, when they really only need the medicine in a small area   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States |  American South |  Atlantic |  Georgia |  Northeast |  Clarke |  Athens | 
Nearly 21 Million Now Receiving AIDS Drugs, U.N. Agency Says
Photo Almost 21 million people around the world are now getting life-prolonging AIDS drugs, according to a report issued on Monday. But another 16 million people infected with H.I.V. are not yet on medication. The report was released in South Africa by Unaids, the joint United Nations AIDS-fighting agency. Antiretroviral triple therapy became standard in wealthy countries in 1996, but it took almost a decade for just one million people in poor countries to receive treatment   Read More ...
Categories: Health | 
Places: United States |